跳至主要内容
临床试验/NCT00267072
NCT00267072已完成不适用

The University of Louisville Ovarian Screening Study

University of Louisville1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2001年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,000
试验地点
1

研究概览

简要总结

The objectives of this study are:

  • To identify women at increased risk for developing ovarian cancer
  • To detect ovarian cancers at an early stage
  • To investigate the role of tumor membrane fragments as tumor markers for early ovarian carcinoma

详细描述

In the year 2001 approximately 23,400 women in the USA are expected to be diagnosed with ovarian carcinoma and 13,900 will die of the disease. This means that within the USA more women die annually from ovarian cancer than all other gynecologic malignancies combined. Within the Commonwealth of Kentucky approximately 250 women per year develop ovarian carcinoma.

Survival for patients with ovarian cancer is directly related to the stage of disease at diagnosis. Unfortunately, the majority of women present with advanced disease (Stage III and IV) and most of these patients will die of the disease.

The aim of screening for ovarian cancer is to reduce the morbidity and mortality by detecting the disease at an early stage since ovarian cancer detected when disease is confined to the ovary (Stage I) is associated with a dramatically improved 5-year survival. Disease confined to the ovary may be cured in over 90% of patients, in some cases without the need for chemotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Asymptomatic women over the age of 45 with one or both ovaries.
  • Women over the age of 25 with one or both ovaries and any of the following:
  • A personal history of breast, colon or endometrial cancer or breast cancer gene (BRCA) 1 or 2 positive
  • First-degree relative (mother, sister, daughter) with ovarian or breast cancer
  • Two family members with either breast and/or ovarian cancer
  • Mother, sister, daughter, grandparent with a positive BRCA1 or BRCA2 genetic test result.
  • Past use of fertility drugs such as Clomid or Pergonal for more than a year.

排除标准

  • Women who are symptomatic of ovarian cancer

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ovarian Screening Study | 临床试验